Attenuation of Mouse Hepatitis Virus by Deletion of the LLRKxGxKG Region of Nsp1

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lei, Lin ^a   Ying, Sun ^b   Baojun, Luo ^a   Yi, Yang ^a   Xiang, He ^a   Wenli, Su ^a   Zounan, Sun ^a   Deyin, Guo ^b   Qingyu, Zhu ^a   Jingmei, Liu ^a   Guohui, Chang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLYCINE; LEUCINE; LYSINE; PROTEIN NSP1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MURINE HEPATITIS CORONAVIRUS; MUTANT; NONHUMAN; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN DOMAIN; REPORTER GENE; RNA VIRUS INFECTION; VACCINIA VIRUS; VIRAL GENETICS; VIROGENESIS; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CONSERVED SEQUENCE; HUMANS; IMMUNIZATION; MICE; MOLECULAR SEQUENCE DATA; MURINE HEPATITIS VIRUS; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION; VIRAL NONSTRUCTURAL PROTEINS;

MURINE HEPATITIS VIRUS; MUS; RNA VIRUSES; VACCINIA VIRUS;

EID: 84875990077     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061166     Document Type: Article

References (30)

1. Weiss SR, Navas-Martin S, (2005) Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 69: 635-664.
2. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, et al. (2003) The genome sequence of the SARS-associated coronavirus. Science 300: 1399-1404.
3. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, et al. (2003) Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423: 240.
4. Perlman S, Dandekar AA, (2005) Immunopathogenesis of coronavirus infections: Implications for SARS. Nat Rev Immunol 5: 917-927.
5. Ziebuhr J, (2005) The coronavirus replicase. Curr Top Microbiol Immunol 287: 57-94.
6. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, et al. (2003) Unique and conserved features of genome and proteome of SARS coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331: 991-1004.
7. Graham RL, Sims AC, Brockway SM, Baric RS, Denison MR, (2005) The nsp2 replicase proteins of murine hepatitis virus and severe acute respiratory syndrome coronavirus are dispensable for viral replication. J Virol 79: 13399-13411.
8. Thiel V, Karl N, Schelle B, Disterer P, Klagge I, et al. (2003) Multigene RNA vector based on coronavirus transcription. J Virol 77: 9790-9798.
9. Chen Y, Cai H, Pan J, Xiang N, Tien P, et al. (2009) Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltrans-ferase. Proc Natl Acad Sci USA 106: 3484-3489.
10. Brockway SM, Denison MR, (2005) Mutagenesis of the murine hepatitis virus nsp1-coding region identifies residues important for protein processing, viral RNA synthesis, and viral replication. Virology 340: 209-223.
11. Züst R, Cervantes-Barragán L, Kuri T, Blakqori G, Weber F, et al. (2007) Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog 3: e109.
12. Kamitani W, Narayanan K, Huang C, Lokugamage K, Ikegami T, et al. (2006) Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci USA 103: 12885-12890.
13. Wathelet MG, Orr M, Frieman MB, Baric RS, (2007) Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. Virol 81: 11620-11633.
14. Kamitani W, Huang C, Narayanan K, Lokugamage KG, Makino S, (2009) A novel two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein. Nat Struct Mol Biol 16: 1134-1140.
15. Almeida MS, Johnson MA, Herrmann T, Geralt M, Wuthrich K, (2007) Novel fbetag-barrel fold in the NMR structure of the replicase nonstructural protein 1 from the SARS coronavirus. J Virol 81: 3151-3161.
16. Battegay M, Cooper S, Althage A, Banziger J, Hengartner H, et al. (1991) Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods 33: 191-198.
17. Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, et al. (2009) Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol 83: 5282-5288.
18. Kopecky-Bromberg SA, Martinez-Sobrido L, Frieman M, Baric RA, Palese P, (2007) Severe acute respiratory syndrome coronavirus open reading frame (ORF)3b, (ORF)6, and nucleocapsid proteins function as interferon antagonists. J Virol 81: 548-557.
19. Cheung CY, Poon LL, Ng IH, Luk W, Sia SF, et al. (2005) Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: Possible relevance to pathogenesis. J Virol 79: 7819-7826.
20. Roth-Cross JK, Martínez-Sobrido L, Scott EP, García-Sastre A, Weiss SR, (2007) Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J Virol 81: 7189-7199.
21. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, et al. (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300: 1394-1399.
22. Vijgen L, Keyaerts E, Lemey P, Moës E, Li S, et al. (2005) Circulation of genetically distinct contemporary human coronavirus OC43 strains. Virology 337: 85-92.
23. Dijkman R, van der Hoek L, (2009) Human coronaviruses 229E and NL63: close yet still so far. J Formos Med Assoc 108: 270-9.
24. de Groot-Mijnes JD, van Dun JM, van der Most RG, de Groot RJ, (2005) Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J Virol 79: 1036-1044.
25. De Haan CA, Masters PS, Shen X, Weiss S, Rottier PJ, (2002) The group specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology 296: 177-189.
26. Connor RF, Roper RL, (2007) Unique SARS-CoV protein nsp1: bioinformatics, biochemistry and potential effects on virulence. Trends Microbiol 15 (2): 51-3.
27. Schelle B, Karl N, Ludewig B, Siddell SG, Thiel V, (2006) Nucleocapsid protein expression facilitates coronavirus replication. Adv Exp Med Biol 581: 43-8.
28. Thiel V, Herold J, Schelle B, Siddell SG, (2001) Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J Gen Virol 82: 1273-1281.
29. Coley SE, Lavi E, Sawicki SG, Fu L, Schelle B, et al. (2005) Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J Virol 79: 3097-3106.
30. Elankumaran S, Chavan V, Qiao D, Shobana R, Moorkanat G, et al. (2010) Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy. J Virol 84 (8): 3835-44.